SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending as investors weigh an upcoming earnings report against the broader uncertainty of a critical FOMC interest rate decision. While the community remains deeply divided between long-term bullish supporters citing record growth and vocal bears pointing to valuation concerns and share dilution, the stock's price action remains a focal point of intense debate ahead of the pending macroeconomic catalyst.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is facing significant selling pressure as investors react to lowered earnings guidance and concerns over slowing demand in key product segments, leading to active community debate regarding whether the stock is an undervalued turnaround play or a long-term value trap. Discussion is dominated by speculation over institutional accumulation versus potential further downside, with traders closely monitoring technical support levels and the impact of the company's recent restructuring program.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is heavily trending ahead of its earnings report, with the community intensely focused on whether the company's fuel cell solutions can solidify their status as a critical power standard for the AI data center boom. While short-sellers and recent market volatility have driven significant price swings, many investors are actively debating if the current pullback offers a strategic entry point or if the stock faces further downside risk following the upcoming earnings update.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings Co is trending as investors react to a revenue miss driven by supply-chain timing and project complexity, despite strong profit growth and raised long-term guidance. The community is actively debating whether the current pullback is an overreaction to temporary logistical bottlenecks or a sign of an unsustainable valuation in the data center infrastructure sector.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is currently drawing significant investor interest following a major strategic partnership with Micron to secure long-term memory and storage supply for its next-generation software-defined vehicles. The community is actively debating the stock's potential as a play on grid-scale energy storage and battery manufacturing, while balancing excitement over these structural business transformations against ongoing concerns regarding vehicle quality recalls and sales fluctuations.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following a major strategic partnership with Jazz Pharmaceuticals to develop T-cell engager therapies, which investors view as a strong validation of its discovery platform. Community discussion is heavily focused on the stock's potential for a short squeeze given high short interest, alongside intense speculation about upcoming clinical data readouts that could serve as a significant catalyst for long-term valuation.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade Inc. shares are experiencing heightened volatility as investors weigh strong quarterly growth metrics and accelerated in-force premium expansion against lingering concerns over the company's path to consistent profitability. The community remains deeply divided, with bulls highlighting the stock as a long-term AI-driven disruptor coiling for a major breakout, while bears express skepticism over the lack of GAAP profit and the stock's recent sharp pullback.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors weigh an upcoming Supreme Court ruling on patent litigation and Q1 earnings, with active discussions focusing on whether the company's positive cash flow and international growth can justify a potential buyout. While some community members remain frustrated by the long-term stock performance and a lack of transparency regarding management's strategic plans, others point to the potential for a new formulation and platform expansion as catalysts for significant future value.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is facing significant volatility as investors react to extreme retail leverage, regulatory crackdowns on single-stock derivative products, and high-stakes labor disputes at major semiconductor firms like Samsung. Market participants are intensely debating whether the ongoing memory chip supercycle provides a long-term accumulation opportunity or if the index, which is heavily concentrated in a few AI-linked tech giants, has reached a structural bubble peak.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood stock is seeing heightened activity as investors weigh a series of positive analyst upgrades and new product rollouts against broader market volatility and uncertainty surrounding upcoming earnings. The community remains deeply divided, with bulls pointing to robust trading volumes and platform innovation, while others express frustration over technical glitches and price action that many perceive as being heavily manipulated.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of Quantum-Sis Board of Directors has granted 134,141 restricted stock units (RSUs) to...

Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus

Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a partnership with Cell Signaling Technology (CST) to advance and validate next-generation protein sequencing and...

Quantum-Si Announces the Expansion of the Proteus Roadshow

Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced the expansion of a roadshow designed to accelerate the education of the market on its Proteus platform and...

Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates

QuantumSi Incorporated (QSI) delivered earnings and revenue surprises of +16.67% and -35.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Quantum-Si (QSI) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus Development Milestones

Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced...

Pitney Bowes (PBI) Q1 Earnings Meet Estimates

Pitney Bowes (PBI) delivered earnings and revenue surprises of 0.00% and +0.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it will be participating in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ, 151 West...

Quantum-Si (QSI) Projected to Post Quarterly Earnings on Thursday

Quantum-Si (NASDAQ:QSI) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Quantum-Si Announces Successful Sequencing on Integrated Proteus Instruments

Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the company has successfully demonstrated sequencing on integrated Proteus instruments. This milestone was...

Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. It engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins in a massively parallel fashion. Its platform includes platinum NGPS instrument, platinum analysis software, and consumable kits for platinum instrument. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.

Quantum-Si Incorporated - Ordinary Shares - Class A

5 Stocks Retail Investors Are Most Bullish On At Mid-Day

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.7606
Prev Close	$0.7834
Open	$0.775
Dividend Yield	0.00%
50-Day Moving Average	$0.9453
Beta	2.51
Avg. Volume	6.57M
PE Ratio	-1.49

52-Week High	$3.10
52-Week Low	$0.6912
Market Capitalization	$165.63M
EPS (Annual)	-$0.5124
Price to Book	0.82
Revenue Per Employee	$16,800.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

QSIQuantum-Si Incorporated - Ordinary Shares - Class A

Latest QSI News